Liposomal composition for use in a method of treating Parkinson's disease
AssigneeInnomedica Holding AG
InventorsStéfan Jonathan Halbherr, Camille Françoise Peitsch
Life of this patent
Estimating the term…
Abstract
A method of treating Parkinson's disease in a subject in need thereof. The method comprises administering a liposomal composition, comprising sphingomyelin in a lipid bilayer and a therapeutically effective amount of GM1, to the subject.
Claims17
A method of treating Parkinson's disease in a subject in need thereof, comprising administering to said subject a liposomal composition comprising sphingomyelin in a lipid bilayer and a therapeutically effective amount of GM1, wherein the liposomal surface is completely free of chemically coupled folic acid, peptides, antibodies, sugars, polyethylene glycol, monoclonal antibodies, fractions of monoclonal antibodies, and surface proteins.
Dependencies are inferred from the claim text.